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Background: HIVrelated mortality remains high in Ukraine with about half of deaths 
happening due to tuberculosis. Until recently, parenteral route of transmission 
accounted for the majority of new HIV cases. Additionally, population of people who 
infect drugs (PWID) in Ukraine has high prevalence of hepatitis C. We hypothesize that 
HIV among PWID is characterized with disadvantageous course with increased risk of 
developing tuberculosis, hepatitis C and rapid progression.  
Materials & Methods: Routine clinical data of 930 HIVinfected patients aged 1565 
years admitted to Poltava (Ukraine) HIV/AIDS clinic in 2003-2010 were considered as a 
retrospective cohort and analyzed using Cox proportional hazards regression model. All 
patients were observed prior to ART prescription, 44% were men, and 47% had 
experience of infecting drugs. Outcome measures included timetodiagnosis of 
tuberculosis, viral hepatitis C and fourth stage of HIV infection. Time of observation was 
considered starting from the first positive HIV test. Route of transmission was 
considered a primary predictor with control of gender, age, and experience of 
incarceration. 
Results: All three outcomes developed earlier among patients who acquired HIV due to 
injection drugs use compared to those with sexual route of transmission. HCV infection 
was found in 507 patients (82% among PWID), HR=3.5 (95%CI 2.84.4). Tuberculosis 
was diagnosed among 210 patients (71% among PWID and 67% among men) with 
HR=1.6 (95%CI 1.22.2). Fourth stage of HIV was diagnosed among 266 patients (67% 
among PWID) with HR=1.5 (95%CI 1.22.0). Hazards of all three outcomes increased 
with age, and men were more likely to develop tuberculosis than women (HR=1.7 
95%CI 1.22.3). PWID demonstrated longer term between first positive HIV test and 
linkage to care. 
Conclusions: PWID are found to be the group of HIV patients who are characterized 
with increases risk of HIV progression and earlier development of HCV coinfection 
which can lead to increased mortality. This is assumingly caused by late linkage to care 
and delayed ARV treatment. Emphasized HIV care and support cascade activities 
aimed at PWID could be an effective means to overcome the revealed peculiarities of 
this highrisk group. 
